Lv1
6 积分 2026-02-26 加入
Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis
2天前
已完结
Treating Hepatorenal Syndrome in the Current Era
6个月前
已关闭
How I Treat Challenging Cases of Antibody-Mediated Glomerular Diseases
6个月前
已完结
Dietary Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic Complications
6个月前
已关闭
The Quest for a Urea Sorbent
6个月前
已关闭
Treatment Approaches for Alport Syndrome
6个月前
已完结
Treatment Approaches for Alport Syndrome
6个月前
已完结
Kidney Disease as a Driver of Immunosenescence
6个月前
已完结
皖公网安备34019202002308
